Cumulative number of drugs with biosimilars approved US and Europe 2006-2018

Published by
Matej Mikulic,
Jul 20, 2020
In 2018, the U.S. Food and Drug Administration (FDA) had cumulatively 12 medicines with biosimilars approved. The statistic illustrates the cumulative number of medicines with biosimilars approved in Europe, the U.S., and Canada from 2006 to 2018.

Cumulative number of medicines with biosimilars approved in the U.S., Europe, and Canada from 2006 to 2018*

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

May 2020

Region

Canada, Europe, United States

Survey time period

2006 to 2018

Supplementary notes

* All available trade names are counted as one biosimilar medicine (e.g., multiple biosimilar trade names referencing the same originator biologic).

Citation formats
Statista Accounts: Access All Statistics. Starting from $588 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$69 USD $49 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you

Global overview

8

U.S. and European landscape

6

Focus: U.S. companies

8

Research & development

6

Products

5

Funding/M&A/IPOs

6

Compensation in biotech

6

Further related statistics

20

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical market in Thailand
Statista Accounts: Access All Statistics. Starting from $588 USD / Year
Learn more about how Statista can support your business.
Menu